Literature DB >> 6364036

Pyrrolizidine alkaloids, flavonoids and volatile compounds in the genus Eupatorium. Eupatorium cannabinum L., an ancient drug with new perspectives.

H Hendriks, T M Malingré, E T Elema.   

Abstract

Within the scope of a study of antitumour compounds in higher plants a survey is given concerning the presence of pyrrolizidine alkaloids, flavonoids and volatile compounds in Eupatorium species. Preliminary results of a phytochemical study of these compounds in E. cannabinum are also presented. From the results of a GC-MS analysis of an alkaloid extract from aerial parts of E. cannabinum the conclusion can be drawn, that the composition of pyrrolizidine alkaloids is more complicated than reported in literature. This is caused by the fact that different stereoisomers exist. The presence of at least two alkaloids with a molecular weight of 283 (supinine or isomers) and four alkaloids with a molecular weight of 299 (echinatine or isomers) could be shown. In subterranean plant material also other pyrrolizidine alkaloids are present. A great number of flavonoids, also as glycosides, have been shown in Eupatorium species, often in low quantities. Rutin, present in many Eupatorium species, could not be detected in subterranean parts of E. cannabinum. Relatively little attention has been paid to the analysis of volatile compounds (essential oils) of Eupatorium species. Thymol derivatives are often reported to be present in Eupatorium species. Thirty-five compounds could be detected by means of a GC-MS analysis in the essential oil of E. cannabinum about which no literature data were available.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6364036     DOI: 10.1007/bf02074855

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  7 in total

1.  [Eupatorium cannabinum L., and old medicinal herb with new perspectives].

Authors:  T M Malingré
Journal:  Pharm Weekbl       Date:  1971-09-24

2.  An improved preparation of tertiary amine N-oxides.

Authors:  J Cymerman Craig; K K Purushothaman
Journal:  J Org Chem       Date:  1970-05       Impact factor: 4.354

3.  Tumor inhibitors. 33. Cytotoxic flavones from eupatorium species.

Authors:  S M Kupchan; C W Sigel; R J Hemingway; J R Knox; M S Udayamurthy
Journal:  Tetrahedron       Date:  1969-04       Impact factor: 2.457

4.  Tumor inhibitors. 8. Eupatorin, new cytotoxic flavone from Eupatorium semiserratum.

Authors:  S M Kupchan; J R Knox; M S Udayamurthy
Journal:  J Pharm Sci       Date:  1965-06       Impact factor: 3.534

5.  [The constituents of the essential oil from Eupatorium japonica Thunb (author's transl)].

Authors:  M Miyazawa; H Kameoka
Journal:  Yakugaku Zasshi       Date:  1977-01       Impact factor: 0.302

6.  Flavonoid constituents from Eupatorium altissimum L. (Compositae).

Authors:  R H Dobberstein; M Tin-wa; H H Fong; F A Crane; N R Farnsworth
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

7.  Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humans.

Authors:  J S Kovach; M M Ames; G Powis; C G Moertel; R G Hahn; E T Creagan
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

  7 in total
  3 in total

Review 1.  Eupatorium cannabinum L. A review emphasizing the sesquiterpene lactones and their biological activity.

Authors:  H J Woerdenbag
Journal:  Pharm Weekbl Sci       Date:  1986-10-17

2.  Reciprocal regulation of adipocyte and osteoblast differentiation of mesenchymal stem cells by Eupatorium japonicum prevents bone loss and adiposity increase in osteoporotic rats.

Authors:  Min-Ji Kim; Woo-Seok Jang; In-Kyoung Lee; Jong-Keun Kim; Ki-Seung Seong; Cho-Rong Seo; No-Joon Song; Min-Hyuk Bang; Young Min Lee; Haeng Ran Kim; Ki-Moon Park; Kye Won Park
Journal:  J Med Food       Date:  2014-06-13       Impact factor: 2.786

3.  Extracting and Analyzing Pyrrolizidine Alkaloids in Medicinal Plants: A Review.

Authors:  Thomas Kopp; Mona Abdel-Tawab; Boris Mizaikoff
Journal:  Toxins (Basel)       Date:  2020-05-13       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.